Chiropractic Chain Cuts Sales Forecast on Softer Demand

Outpatient practice operators should expect weaker patient volumes and lower per-patient spending through 2026.

Updated on Nov. 9, 2026 in Healthcare

Chiropractic Chain Cuts Sales Forecast on Softer Demand

Live Poll

Have you skipped or delayed a routine checkup because of cost this year?

The Joint Corp. lowered its 2026 system-wide sales forecast to $508 million-$512 million, down from $519 million-$552 million, while keeping its adjusted EBITDA forecast at $12.5 million-$13.5 million. The chiropractic franchisor, which operates 930 clinics, now expects comparable sales to fall 2.5%-3.5% this year.

Why it matters

The revision reflects weaker patient spending and fewer new patients, according to CEO Sanjiv Razdan, who cited macroeconomic pressures. For operators of franchised and multi-location healthcare practices, the figures signal softer demand for elective outpatient care.

Q3 system-wide sales fell 3.1% year over year to $123.3 million, while comparable sales declined 1.9%, an improvement on the 2.8% drop recorded in Q2. The company's 930 clinics at Sept. 30 included 915 franchised locations and 15 company-owned or managed sites.

The players

The Joint Corp.

A franchisor of chiropractic clinics that operates a network of 930 locations, with the vast majority franchised rather than company-owned.

Sanjiv Razdan

The chief executive of The Joint Corp., who attributed the revised outlook to macroeconomic challenges, lower average monthly patient spending, and fewer new patients.

The details

Comparable sales measure clinics open at least 13 full months and exclude closed locations, so the metric isolates same-store performance. Sales at franchised clinics are not recorded as The Joint Corp.'s revenue, which means the company's reported revenue of $13.6 million for the quarter, up 1%, reflects its own structure rather than the full network's sales. The company now expects its clinic count at the end of 2026 to be about 50 below year-end 2025.

Timeline

  1. Sept. 30, 2025: Second-quarter comparable sales decline of 2.8% reported.

  2. Sept. 30, 2026: Quarter-end clinic count of 930 and third-quarter sales reported.

  3. Nov. 5, 2026: Sales forecast lowered to $508 million-$512 million.

Market Landscape

The Joint Corp.'s quarterly comparable sales have contracted, with the most recent decline narrowing from the second quarter. Its forecast revision points to continued softness in franchised outpatient chiropractic demand rather than a single-quarter disruption.

Operators of franchised or multi-location healthcare practices should factor in softer patient volumes and lower per-patient spending when reviewing 2026 revenue assumptions. The lowered forecast suggests that demand softness may persist through the year rather than reverse quickly.

The takeaway

Franchise owners and healthcare operators should treat the projected decline in comparable sales and roughly 50-clinic reduction as signals to stress-test their own patient-volume and new-patient assumptions for 2026. Monitoring the company's next quarterly report for whether comparable sales continue to narrow will indicate whether the downturn is stabilizing.

Further reading

For broader context on how demand and reimbursement pressures are reshaping outpatient care, see Healthcare coverage.

Source note: This article includes information reported by TokenPost.

Live Poll

Have you skipped or delayed a routine checkup because of cost this year?